한글목차

세계의 헤모글로빈 A1c 검사 기기 및 키트 시장 규모는 2023년 21억 달러에서 예측 기간 중 9.2%의 CAGR로 추이하며, 2028년에는 32억 달러 규모로 성장할 것으로 예측됩니다.

기술별로 보면 크로마토그래피 부문은 2023년 9억 4,060만 달러에서 8.1%의 CAGR로 추이하며, 2028년에는 14억 달러 규모로 성장할 것으로 예측됩니다. 또한 어세이 기술 부문은 2023년 7억 2870만 달러에서 9.8%의 CAGR로 추이하며, 2028년에는 12억 달러 규모로 성장할 것으로 예측됩니다.

세계의 헤모글로빈 A1c 검사 기기 및 키트 시장을 조사했으며, 시장·질환·기술의 개요, 시장 영향요인 분석, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 기술 동향, ESG 개발, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 요약·하이라이트

제3장 시장 개요

• 개요
• 당뇨병이란?
• 당뇨병의 유형
• 1형 당뇨병
• 2형 당뇨병
• 임신성 당뇨병(GDM) 또는 임신중 고혈당
• 내당능 이상(IGT) 및 공복시 혈당 이상(IFG)
• 당뇨병의 역학
• 성별 분포
• 지역 격차
• A1c 검사
• A1c 검사의 중요성
• HbA1c 진단의 가능성
• 인정된 A1c 검사 디바이스

제4장 시장 역학

• 시장 역학
• 촉진요인
• 억제요인
• 기회

제5장 세계의 헤모글로빈 A1c 검사 기기 및 키트 시장 : 기술별

• 크로마토그래피
• 고속 액체 크로마토그래피(HPLC)
• 양이온 교환 HPLC
• 붕소산 어피니티 크로마토그래피
• 모세관 전기영동(CE)
• 어세이 기술
• 면역측정법
• 효소 어세이

제6장 세계의 헤모글로빈 A1c 검사 기기 및 키트 시장 : 최종사용자별

• 개요
• 상업 랩
• POC(Point of Care) 환경
• POC 검사의 이점
• POC 검사의 용도
• 병원·진료소
• 홈케어 조직
• 기타 POC

제7장 세계의 헤모글로빈 A1c 검사 기기 및 키트 시장 : 지역별

• 북미
• 미국
• 캐나다
• 멕시코
• 유럽
• 독일
• 이탈리아
• 프랑스
• 영국
• 스페인
• 기타 유럽
• 아시아태평양
• 일본
• 인도
• 호주 및 뉴질랜드
• 중국
• 기타 아시아태평양
• 기타 지역
• 브라질
• GCC 국가
• 기타

제8장 헤모글로빈 A1c 검사 기기 및 키트 업계의 지속가능성 : ESG 관점

• 헤모글로빈 A1c 검사 기기 및 키트 제조업에서 ESG의 중요성
• ESG 평가와 지표 : 데이터 이해
• 향후 동향
• 헤모글로빈 A1c 검사 기기 및 키트 제조업계에서의 ESG 실천
• 환경면 퍼포먼스
• 사회면 퍼포먼스
• 거버넌스면 퍼포먼스
• 사례 연구
• BCC에 의한 견해

제9장 당뇨병 진단 업계에서 신규 기술 : 정성적 관점

• 당뇨병 의료기기 업계의 새로운 동향
• 헤모글로빈 A1c 검사 기기 및 키트의 개발

제10장 M&A 및 벤처 자금조달 전망

제11장 경쟁 구도

제12장 기업 개요

• ABBOTT
• ARKRAY INC.
• BAYER AG
• BIO-RAD LABORATORIES INC.
• DANAHER
• EKF DIAGNOSTICS HOLDINGS PLC
• F. HOFFMANN-LA ROCHE AG
• LUMIRADX
• MERIL LIFE SCIENCES PRIVATE. LTD.
• OSANG HEALTHCARE CO. LTD.
• SIEMENS HEALTHCARE GMBH
• SINOCARE INC.
• THERMO FISHER SCIENTIFIC INC.
• TRINITY BIOTECH PLC
• WUXI BIOHERMES BIOMEDICAL TECHNOLOGY CO. LTD.
• XIAMEN BIOTIME BIOTECHNOLOGY CO. LTD.

제13장 부록

영문목차

Highlights:

The global market for hemoglobin A1c testing devices and kits is estimated to increase from $2.1 billion in 2023 to reach $3.2 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.

The global market for chromatography segment of hemoglobin A1c testing devices and kits is estimated to increase from $940.6 million in 2023 to reach $1.4 billion by 2028, at a CAGR of 8.1% from 2023 through 2028.

The global market for assay techniques segment of hemoglobin A1c testing devices and kits is estimated to increase from $728.7 million in 2023 to reach $1.2 billion by 2028, at a CAGR of 9.8% from 2023 through 2028.

Report Scope:

This report aims to provide a comprehensive study of the global market for Hemoglobin A1c Testing Devices & Kits. It describes the different types of Hemoglobin A1c Testing Devices & Kits products, technology, and their current and historical market revenues.

This report discusses the implications of the trends mentioned above in the context of the current size and growth of the diabetes market, in global terms and by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the leading drug and device categories as well as breakdowns of the diabetes market by country.

Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for the Market for Hemoglobin A1c Testing Devices and Kits.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data is provided for 2022 as the base year, 2023, and forecast through year-end 2028.

Report Includes:

• 131 data tables and 46 additional tables
• An overview of the global market landscape related to the hemoglobin A1c testing devices and kits
• In-depth analysis of global market trends, featuring historical revenue data for 2020- 2022, estimated figures for 2023, as well as forecasts for 2023-2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
• Evaluation of the current market size and revenue growth prospects specific to hemoglobin A1c testing devices and kits, accompanied by a comprehensive market share analysis categorized by technology, end user, and geographical region
• Understanding of the upcoming market potential for hemoglobin A1c test devices and kits, and areas of focus to forecast this market into various segments and sub-segments
• In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, regulations, prospects, and contributions to the overall market
• Discussion of the role and importance of ESG in HbA1c test devices and kits market, consumer attitudes, risks and opportunity assessment, and ESG practices in the industry
• Identification of the major stakeholders and analysis of their company competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
• Detailed profiles of leading market participants including Abbott, Siemens Healthineers, Bayer AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories Inc., providing a descriptive overview of their respective businesses

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology
• Secondary Research
• Primary Interviews
• Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview

• Overview
• What is Diabetes?
• Types of Diabetes
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes Mellitus (GDM) or Hyperglycemia in Pregnancy
• Impaired Glucose Tolerance (IGT) and Impaired Fasting Glucose (IFG)
• Epidemiology of Diabetes
• Gender Distribution
• Regional Disparities
• A1C Test
• Importance of A1C Test
• Diagnostic Potentials of HbA1c
• Certified A1C Test Devices

Chapter 4 Market Dynamics

• Market Dynamics
• Drivers
• Restraints
• Opportunities

Chapter 5 Global Market for Hemoglobin A1c Testing Devices and Kits by Technology

• Introduction
• Chromatography
• High-Performance Liquid Chromatography (HPLC)
• Cation-Exchange HPLC
• Boronate Affinity Chromatography
• Capillary Electrophoresis (CE)
• Assay Techniques
• Immunoassay
• Enzymatic Assay

Chapter 6 Global Market for Hemoglobin A1c Testing Devices and Kits by End User

• Overview
• Commercial Laboratories
• Point of Care Settings
• Benefits of POC Testing
• PoC Testing Applications
• Hospitals and Clinics
• Home Care Organizations
• Other POCS

Chapter 7 Global Market for Hemoglobin A1c Testing Devices and Kits by Region

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• Italy
• France
• United Kingdom
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• India
• Australia & New Zealand (ANZ)
• China
• Rest of Asia-Pacific
• Rest of World
• Brazil
• GCC Countries
• Other RoW Countries

Chapter 8 Sustainability in the Hemoglobin A1c Testing Devices and Kits Industry: An ESG Perspective

• Importance of ESG in Hemoglobin A1c Testing Devices and Kits Manufacturing Industry
• ESG Ratings and Metrics: Understanding the Data
• Future Trends
• ESG Practices in the Hemoglobin A1c Testing Devices and Kits Manufacturing Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Case Study
• BCC Research Viewpoint

Chapter 9 Emerging Technology in the Diabetes Diagnosis Industry: Qualitative Perspective

• Introduction
• Emerging Trends in the Diabetes Medical Devices Industry
• Developments in Hemoglobin A1c Testing Devices and Kits

Chapter 10 M&A and Venture Funding Outlook in the Market

• M&A Analysis

Chapter 11 Competitive Landscape

Chapter 12 Company Profiles

• ABBOTT
• ARKRAY INC.
• BAYER AG
• BIO-RAD LABORATORIES INC.
• DANAHER
• EKF DIAGNOSTICS HOLDINGS PLC
• F. HOFFMANN-LA ROCHE AG
• LUMIRADX
• MERIL LIFE SCIENCES PRIVATE. LTD.
• OSANG HEALTHCARE CO. LTD.
• SIEMENS HEALTHCARE GMBH
• SINOCARE INC.
• THERMO FISHER SCIENTIFIC INC.
• TRINITY BIOTECH PLC
• WUXI BIOHERMES BIOMEDICAL TECHNOLOGY CO. LTD.
• XIAMEN BIOTIME BIOTECHNOLOGY CO. LTD.

Chapter 13 Appendix

• Government Regulatory Agencies and Professional Organizations